-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PedgRr0ivp0ez49ghqT79PNesr6csjcvJC+tKk2G+pG4AjehRac2Nfw0lFmamhmB Y9unOtOGXUaQfSngCleBZg== 0000950144-06-009748.txt : 20061024 0000950144-06-009748.hdr.sgml : 20061024 20061024160859 ACCESSION NUMBER: 0000950144-06-009748 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20061024 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20061024 DATE AS OF CHANGE: 20061024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDCATH CORP CENTRAL INDEX KEY: 0001139463 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 562248952 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33009 FILM NUMBER: 061160368 BUSINESS ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 7047086600 MAIL ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 8-K 1 g03761ke8vk.htm MEDCATH CORPORATION MedCath Corporation
 

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Date of Report (Date of earliest event reported): October 24, 2006
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction of
incorporation or organization)
  000-33009
(Commission File Number)
  56-2248952
(IRS Employer Identification No.)
10720 Sikes Place
Charlotte, North Carolina 28277

(Address of principal executive offices, including zip code)
(704) 708-6600
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))
 
 

 


 

Item 8.01. Other Events
On October 24, 2006, MedCath Corporation (MedCath or the Company) announced that the The Lewin Group, Inc., a nationally recognized consultant to the health and human services industries, has completed a national study which demonstrates again that MedCath heart hospitals deliver superior clinical results in several critical patient categories. A copy of the press release is included as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
Exhibit 99.1      Press Release dated October 24, 2006
 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MEDCATH CORPORATION
 
 
Date: October 24, 2006  By:   /s/ James E. Harris    
    James E. Harris   
    Executive Vice President and Chief Financial Officer   

 

EX-99.1 2 g03761kexv99w1.htm EX-99.1 Ex-99.1
 

         
Exhibit 99.1
     (MEDCATH CORPORATION LOGO)
MEDCATH CONTACTS:
     
O. Edwin French
  James E. Harris
President & Chief Executive Officer
  Chief Financial Officer
(704) 708-6600
  (704) 708-6600
NATIONAL STUDY SHOWS MEDCATH HOSPITALS EXCEL
IN KEY PATIENT CARE MEASURES
For Sixth Consecutive Year, MedCath Hospitals on Average Show Lower Mortality
Rates and Shorter Lengths of Stay than Peer Hospitals
     CHARLOTTE, N.C. (Oct 24, 2006) — The Lewin Group, Inc., a nationally recognized consultant to the health and human services industries, has completed a national study which demonstrates again that MedCath heart hospitals deliver superior clinical results in several critical patient categories, MedCath Corporation (NASDAQ: MDTH), announced today.
     The report, “A Comparative Study of Patient Severity and Quality of Care between MedCath Heart Hospitals and Peer Hospitals for 2005 Discharges,” analyzes publicly available Medicare data for the federal fiscal year 2005 — the latest year available. Compared with the 1,109 U.S. hospitals that perform open-heart surgery, the report indicated that MedCath heart hospitals:
    Exhibit a 29.4 percent lower in-hospital risk-adjusted mortality rate for Medicare cardiac cases.
 
    Have 24.9 percent shorter lengths of stay for cardiac cases, on a severity-adjusted basis.
 
    Are 22.9 percent more likely to discharge patients to their homes rather than another medical care facility.
 
    Have a 23.7 percent higher case mix for cardiac patients, on an APR-DRG severity adjusted basis, which takes into account case complexity and patient severity.
     This is the sixth consecutive year that MedCath contracted with Lewin to conduct the study, and the results are consistent with the previous five years. The 12 hospitals that MedCath operated in the fiscal year that ended Sept. 30, 2005 were compared with the 1,109 peer hospitals that perform open-heart surgery in the United States (205 of which were major teaching hospitals — hospitals that have an interns and residents to bed ratio of 0.25 and above).

 


 

     “We are proud of the excellent clinical results at our hospitals,” said Ed French, MedCath’s president and chief executive officer. “We are particularly pleased that we have been able to achieve these excellent results year after year. We always have believed in our patient-focused approach, which features close cooperation with physicians to provide the best environment to treat cardiovascular disease. Once again, Lewin’s extensive study of the data demonstrates that our approach is yielding superior results.”
     The Lewin study results, for the latest year and recent years:
                       
 
  Category     Year     MedCath     Peer Hospitals  
 
 
    2005     1.51%     2.14%  
 
In-hospital mortality rates, risk adjusted
    2004     1.86%     2.31%  
 
 
    2003     1.94%     2.36%  
 
 
                   
 
 
    2005     3.52 days     4.69 days  
 
Average Length of Stay, severity adjusted
    2004     3.46 days     4.75 days  
 
 
    2003     3.69 days     4.79 days  
 
 
                   
 
 
    2005     84.7%     68.9%  
 
% Patients Discharged to Home
    2004     83.8%     68.8%  
 
 
    2003     86.9%     71.1%  
 
     An executive summary of the report is available at www.medcath.com.
     Part of Quintiles Transnational Corp., The Lewin Group is a Falls Church, Va.-based health and human services consulting firm with more than 30 years of experience finding answers and solving problems for key organizations in the public, non-profit and private sectors.
     MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused primarily on the diagnosis and treatment of cardiovascular disease. MedCath focuses on serving the unique needs of patients suffering from cardiovascular disease. MedCath owns interests in and operates eleven hospitals with a total of 667 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath manages the cardiovascular program at various hospitals operated by other parties. Further, MedCath provides cardiovascular care services in diagnostic and therapeutic facilities located in various states.
-# # #-

 

GRAPHIC 3 g03761kg0376100.gif GRAPHIC begin 644 g03761kg0376100.gif M1TE&.#EA-0%,`/<``````(````"``("`````@(``@`"`@,#`P,#&O\A M'?\A)O\I(?\K*/\K,?\O*_\Q,?\R-_\W,_\X./\[0?\^._\^1/]#2?](1/]( M2?],3_]/3/]15/]36?]97/]=8?]@7O]B8/]E:/]H9O]I:_]M=/]SO]Y M>_]^@/^"A/^'B?^*C/^.DO^3E?^6F?^I?^AGO^DI_^FJ_^NL/^O ML_^SM/^TNO^\OO^_PO_$P__&S/_+R?_-S__/U__3T?_4T__4W/_>UO_;WO_? MZ/_GYO_I\/_G]__OY__M\?_Q]O_Y^?_Y_O_^_@`````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````/_[\*"@I("`@/\```#_ M`/__````__\`_P#______R'Y!```````+``````U`4P`AP```(````"``("` M````@(``@`"`@,#`P,#&O\A'?\A)O\I(?\K*/\K,?\O*_\Q,?\R-_\W M,_\X./\[0?\^._\^1/]#2?](1/](2?],3_]/3/]15/]36?]97/]=8?]@7O]B M8/]E:/]H9O]I:_]M=/]SO]Y>_]^@/^"A/^'B?^*C/^.DO^3E?^6F?^< ME/^;G?^>I?^AGO^DI_^FJ_^NL/^OL_^SM/^TNO^\OO^_PO_$P__&S/_+R?_- MS__/U__3T?_4T__4W/_>UO_;WO_?Z/_GYO_I\/_G]__OY__M\?_Q]O_Y^?_Y M_O_^_@`````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````/_[\*"@I("`@/\```#_`/__````__\`_P#______PC^`-L('$BP MH,&#"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>%8;0H40)D!@V3)F.,5*(E MS,>7,&,.C+'A)(V:)G'>M%D3QL,A,G0*Y(8)1LZ*"` MJM6J6*]:E:!#B1>D'F'L9$K6*=B$:;*JU;J6C4,0:^.RE7&VHPRY:K,X-*-$ M`MN_>*W&J+L1,-LTA`UF,1Q8@9:&6QH;SI%8XU3)#_2AH:>1TW-NB+-$HO9&.D-&VK,VX7-'/%2.X.@Q/2YM@$ M"4$S.]8H7.Q;+9"&):IKM2V4-D<4NM9>-?C"M.1=Q5UW$AW76$)/!,A?95[$P)D."6GQFG\9'>'6"P-A M*(1;""FAH%4,>'8Z(E4L*L2`D53*:V)"!AE%(4()'5E<9C7(E*9"$DEDY$8XO:($$$0)E M@45"+([XA$)F1-G!F4I&Y)Y!5+088&74,::E%J5I*=$1B+D@T`G2_<#A04I$ M:81"92JX19L1O08A066$H*8"+*!$PPJ`$5G7%5E&^)J>$<77AA`"20$%&S@B M1(2<3AJT@IK^0#HDDA(Y%#52K!J!L<5*(SV1A1IY%L2D=C]8449"6=`ZWI@* MK;$%%2,!,50.(VEQ+$-+=,9%0E0")F.R18PEPZT+,>'<0&7P@%A"P\[9GIP* M++J;$M^YQR9%82C1[H@#0C&B!%)$%`817QFTZ[ZK]9C-$.E>E@1D"N3QI;%:4)F^BDEG`/U@0V?R M$LH`O"Q%8;;44+11:-`=Q,;T7X]A.B+^`T]/5#9; M-3!A)T*!25%#S`>M$76`8B.T!M9TJZ5Q&Y#[)C-&=;Y-1K9O/S9W8UA8`"]& MG,W@16"M%LU8&RCCU?5`;.3\-@N#&@3&!V_C/9!V/T?T.=TM,)&[YZ\]H/-U M%C4&(6<'5%#VZ/_%91NB&(;Y`GD#!LD#'^+!`6?TQ@$KV!1R`^>PE@B`B$E1C! M?7C!0>X$H@,6LB6(+VS,8]+4I(($QH%'%,C=UN+"&>50C.5AF_#F=['J3(XC M>`*.$BXWD#&\A@,\04%I:C`4G[0A@)&KR`RSHC'<`28$!($A"`5R1C9(JC/K M*H@))#.YZEAIC%JYTF]>,H4.["`*M6-79VI`$,XQ+R%09$P(E+`N,`A!.Q59 MH5J(E$JL$$T@#(P+#\,XP,[L`"$YZ`R;,*D6M@U$EEK9`!I?(X&7>$%]"SF! M9)*SS`.QJSHLD$X%ET,18G;@F%\,80-W5[J!5)&#!D%F5FPSR:<8PWB06K+%!*$<2#LQ0Q$;1E`@$/260,"PNH'$TZ&E*9A! M!->8V%"A-"709I#**3??*%,X6]B,;P;DO(,B!)!T%$CXSB@1?RK@`SHTS*-R MR18>*O![;>B6">O&OT\M9)[RI$T]P6*&*`#AD98DB$NI,M282H:$".$4/R.R M.">-)RXD%*%5'-B&S`&&/8/<7FRNRIA;)L2@AOE!-3F*E'R5-$`#JM]'$4(; M/7E5+A:H2`E2=+75F:&A`M&I5ORC3NO%IC185,A2%6";>5(%!#+9`A`,>32E M/O1=DMD?9OE*$>-C5RXK4BHY1I%PTP)#ZV29IW/S^R!/(:K:0 MU2]U!(FM5 MAK3PNRQIM`L5]GG1,!D`[#X;\\[%!JV`Z+RF=QE)&^QBI)<[Q95/$7+7OWR6 MKI+!+61^2Y`)5@>[A:V*;9(K)]#R=[N-Z1IE.0/9C<#7@-9U+D*,2T,$,\:] M#DFH7&2VT@#);)ZV09$U8SG?A'@0<0()YD@U8H8?:B>\*$9B>@M2W[78K,2^ M2W!!I/"O='+PK7*Y2("9NA"IZKA4VGEC13I6'1,`X0IM.!W7G#JX"2N-(#MCUHDX=@$+";/^86)5!O*`0+,4.3%G&`"$)Y39L02I ML5;4VJ'7I#2W,WX(D*]RD!'!62"N76O\*D+AK%0A(8XL#B)[54F:"!'LZKXDN1`8*&$*1Y\L#J=^]L!G0AU2'5)EFJ02/ M-`,E4&$+H=05M'20,RM$#U$L!7556H"063?[TU>>2&-620Q2(%`'$10 M9,<8(FQ@*Z3^?G-J@V@O,)-3[6M*0#$;M^SA6#G(;':ZEC\VYCX(X?=?2MX& M``D)T=H^B)$9\S^'-+JI;=!J7*!-3BU:UH16R"[-,VD0-HANZE5IYFGEP@`H M:%,+3SC78NO9(GJW(=5LB76?/_X0#?]%OP?7"KYEG+&`[Q3@0S:;?MO@,:Q_ M)N]:*;C-12Z_$?EGP7+9.SBGK.7&8!B]G.'Y=X^\>/0ECK8&1'H;PG#U#X*I MS0(42.?Q4D_`J\5&;_KI5!_"9,-82=U,W]AK`*[S*)D`>P]7?.$-:!OS9H5# M$RH(&Q#_FG<&?R'NC@M%HFH9P_)02V>NO$Z+TK7@JT(JNF4+"VI@1Y#(4,H5N,:$=8(H]=Y*_6:0#P0!8V068Z5L:^A`UB(@C\)K# M.1AI8:7KD`U$%T-2="G`#D90& M`(EM$A$#S3F4#U"ABDHX,DD0/(8"`FJ?QQFALSJI`G$#:!D1,6D1FBD1?[6K M:=H!QQH1PB-\(%(1:P"0'=``5H&'"F$%&V2,#1!UG54$`^&73P@15>`8&G%. M**`>/*">LO&D]@>O]+4F-X.@$M$;%J&O%)$N6:='H$H1X6,0G),16R`%5K`% M+,H0K$B*W+F);$"*MJB*;2*QX$:Q&)NQ&KNQ'-NQ'JL09/`%80`&(UNR)'NR M)INR*+NR*MMJLBS[LBX;LS`[LS);LS1[LS:;LSB[LSK;LSS[LSX;M$#[!<)I M$#V``BB0`DF[M$K;M$S[M$X;M5`[M5);M51[M5:;M5B[M5K;M5S[M5X;MF`[ ;MF);MF1[MF:;`NSVL6S;MF[[MG`;MVT0$``[ ` end
-----END PRIVACY-ENHANCED MESSAGE-----